Reported Standalone quarterly numbers for Indo US Bio-Tech are:Net Sales at Rs 33.38 crore in March 2025 up 111.75% from Rs. 15.77 crore in March 2024.
Story continues below Advertisement
Quarterly Net Profit at Rs. 3.68 crore in March 2025 up 602.78% from Rs. 0.52 crore in March 2024.
EBITDA stands at Rs. 4.70 crore in March 2025 up 298.31% from Rs. 1.18 crore in March 2024.
Indo US Bio-Tec EPS has increased to Rs. 1.86 in March 2025 from Rs. 0.26 in March 2024.
Indo US Bio-Tec shares closed at 149.19 on May 23, 2025 (NSE) and has given -41.64% returns over the last 6 months and -49.01% over the last 12 months.
| Indo US Bio-Tech | | Standalone Quarterly Results | in Rs. Cr. |
|
| Mar'25 | Dec'24 | Mar'24 | | Net Sales/Income from operations | 33.38 | 23.56 | 15.77 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 33.38 | 23.56 | 15.77 | | EXPENDITURE | | Consumption of Raw Materials | -- | 16.37 | -- | | Purchase of Traded Goods | 20.08 | 0.24 | 0.20 | | Increase/Decrease in Stocks | -26.50 | -0.95 | -25.70 | | Power & Fuel | -- | -- | -- | | Employees Cost | 0.34 | 0.23 | 0.20 | | Depreciation | 0.56 | 0.16 | 0.20 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 34.88 | 2.13 | 40.10 | | P/L Before Other Inc. , Int., Excpt. Items & Tax | 4.02 | 5.38 | 0.77 | | Other Income | 0.12 | 0.02 | 0.21 | | P/L Before Int., Excpt. Items & Tax | 4.14 | 5.40 | 0.98 | | Interest | 0.26 | 0.38 | 0.36 | | P/L Before Exceptional Items & Tax | 3.88 | 5.02 | 0.63 | | Exceptional Items | -- | -- | -- | | P/L Before Tax | 3.88 | 5.02 | 0.63 | | Tax | 0.19 | -0.04 | 0.11 | | P/L After Tax from Ordinary Activities | 3.68 | 5.05 | 0.52 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | 3.68 | 5.05 | 0.52 | | Equity Share Capital | 20.05 | 20.05 | 20.05 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | 1.86 | 2.52 | 0.26 | | Diluted EPS | 1.86 | 2.52 | 0.26 | | EPS After Extra Ordinary | | Basic EPS | 1.86 | 2.52 | 0.26 | | Diluted EPS | 1.86 | 2.52 | 0.26 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
